Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Resolution of translation start site for the human Kell glycoprotein.

Blacken GR, Zimring JC, Fu X.

Transfusion. 2013 Nov;53(11 Suppl 2):2882-6. doi: 10.1111/trf.12267. Epub 2013 May 30.

PMID:
23721226
2.
3.

Organization of the gene encoding the human Kell blood group protein.

Lee S, Zambas E, Green ED, Redman C.

Blood. 1995 Mar 1;85(5):1364-70. Erratum in: Blood. 1996 Jun 1;87(11):4922.

4.

The Kell blood group system.

Redman CM, Lee S.

Transfus Clin Biol. 1995;2(4):243-9. Review.

PMID:
8542022
5.

The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function.

Lee S, Russo DC, Pu J, Ho M, Redman CM.

Immunogenetics. 2000 Nov;52(1-2):53-62.

PMID:
11132157
6.

Molecular defects underlying the Kell null phenotype.

Lee S, Russo DC, Reiner AP, Lee JH, Sy MY, Telen MJ, Judd WJ, Simon P, Rodrigues MJ, Chabert T, Poole J, Jovanovic-Srzentic S, Levene C, Yahalom V, Redman CM.

J Biol Chem. 2001 Jul 20;276(29):27281-9. Epub 2001 May 24.

7.

Identification of a defect in the intracellular trafficking of a Kell blood group variant.

Yazdanbakhsh K, Lee S, Yu Q, Reid ME.

Blood. 1999 Jul 1;94(1):310-8.

8.

Molecular cloning and primary structure of Kell blood group protein.

Lee S, Zambas ED, Marsh WL, Redman CM.

Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6353-7.

9.

Kx, a quantitatively minor protein from human erythrocytes, is palmitoylated in vivo.

Carbonnet F, Hattab C, Callebaut I, Cochet S, Blancher A, Cartron JP, Bertrand O.

Biochem Biophys Res Commun. 1998 Sep 29;250(3):569-74.

PMID:
9784384
10.

A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.

Poole J, Warke N, Hustinx H, Taleghani BM, Martin P, Finning K, Crew VK, Green C, Bromilow I, Daniels G.

Transfusion. 2006 Nov;46(11):1879-85.

PMID:
17076841
11.

Molecular basis for the high-incidence antigens of the Kell blood group system.

Lee S, Naime DS, Reid ME, Redman CM.

Transfusion. 1997 Nov-Dec;37(11-12):1117-22.

PMID:
9426633
12.

Functional and structural aspects of the Kell blood group system.

Lee S, Russo D, Redman C.

Transfus Med Rev. 2000 Apr;14(2):93-103. Review.

PMID:
10782495
13.

A murine monoclonal antibody against Kx protein which reacts also with beta-spectrin.

Carbonnet F, Blanchard D, Hattab C, Cochet S, Petit-Leroux Y, Loirat MJ, Cartron JP, Bertrand O.

Transfus Med. 2000 Jun;10(2):145-54.

PMID:
10849386
14.
15.

Diversity of translation start sites may define increased complexity of the human short ORFeome.

Oyama M, Kozuka-Hata H, Suzuki Y, Semba K, Yamamoto T, Sugano S.

Mol Cell Proteomics. 2007 Jun;6(6):1000-6. Epub 2007 Feb 21.

16.

Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel).

Zhu X, Rivera A, Golub MS, Peng J, Sha Q, Wu X, Song X, Kumarathasan P, Ho M, Redman CM, Lee S.

Am J Hematol. 2009 Aug;84(8):492-8. doi: 10.1002/ajh.21453.

17.

The Kell blood group system: Kell and XK membrane proteins.

Lee S, Russo D, Redman CM.

Semin Hematol. 2000 Apr;37(2):113-21. Review.

PMID:
10791880
18.

Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.

Lee S, Debnath AK, Wu X, Scofield T, George T, Kakaiya R, Yogore MG 3rd, Sausais L, Yacob M, Lomas-Francis C, Reid ME.

Transfusion. 2006 Aug;46(8):1323-7. Erratum in: Transfusion. 2006 Oct;46(10):1852.

PMID:
16934067
19.

Proteolytic processing of big endothelin-3 by the kell blood group protein.

Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, Redman C.

Blood. 1999 Aug 15;94(4):1440-50.

20.

Molecular basis of the Kell (K1) phenotype.

Lee S, Wu X, Reid M, Zelinski T, Redman C.

Blood. 1995 Feb 15;85(4):912-6.

Supplemental Content

Support Center